Making Strides (8pm) - a podcast by WBZ-AM

Jordan Rich Fills in - Various biotech companies have been competing for who will come up with the first most effective COVID-19 vaccine. Last week Pfizer reported it had a vaccine that reached a 90% effectiveness in its late stage trials and this week Moderna, a Boston based biotech company, reported its vaccine to have a 94.5% effectiveness in late stage trials. Here to discuss future vaccine distribution and how it would change our country is the President and CEO of the Massachusetts Biotechnology Council, Robert Coughlin.

Further episodes of NightSide With Dan Rea

Further podcasts by WBZ-AM

Website of WBZ-AM